The report by GlobalData, a data and analytics company, showed that anti-obesity medications are the industry trend that will ...

Popular weight management drugs like Ozempic only come in injectable form ... companies are working to create a pill version of a glucagon-like peptide 1 (GLP-1) receptor agonist, which would ...

Researchers from Canada reviewed the results of 26 trials to determine which of the weight loss jabs are the most effective ...

Its active ingredient is semaglutide, a glucagon-like peptide-1 (GLP-1 ... is available by prescription only and is used as a weekly injection to help with blood sugar management and help reduce ...

Dual- and triple-agonist GLP-1s appear to achieve greater weight loss in an overview of clinical trials of approved and ...

I nvesting.com -- The European market is facing shortages of Novo Nordisk's (NYSE:NVO) injectable glucagon-like peptide-1 receptor agonist (GLP-1 RA), Ozempic, a critical medication for managing ...

The FDA has approved Liraglutide Injection, the first generic version of Victoza, for the treatment of type 2 diabetes.

Second, Amneal has received approval from the FDA for exenatide, which is the Company’s first generic injectable glucagon-like peptide-1 (GLP-1) agonist and reflects its innovation capabilities ...

Newly launched company, Verdiva Bio, is aiming to advance oral and injectable drugs for obesity, with it backed by an ...